| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |